Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind Randomized Controlled Trial to Evaluate Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment

NCT06704360 is registered in ClinicalTrials.gov with Dingqun Bai as lead sponsor.

NCT NCT06704360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06704360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind Randomized Controlled Trial to Evaluate Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment
Lead sponsor
Dingqun Bai
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 1, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, stroke